RxDoctor Payments DataLook up a doctor →

Zelboraf: payments to doctors

Payments that named Zelboraf as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$76K
Providers
21
Transactions
42
Average per transaction
$1,801

The per-transaction average — $1,801 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 21 providers the average total is $3,601, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
F. Hoffmann-la Roche AG$75,48399.8%
Genentech USA, Inc.$810.1%
Genentech, Inc.$480.1%
Roche Products Limited$140.0%
← All drugs & devices